These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33185357)

  • 21. Biological foundations of successful bacteriophage therapy.
    Venturini C; Petrovic Fabijan A; Fajardo Lubian A; Barbirz S; Iredell J
    EMBO Mol Med; 2022 Jul; 14(7):e12435. PubMed ID: 35620963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.
    Anyaegbunam NJ; Anekpo CC; Anyaegbunam ZKG; Doowuese Y; Chinaka CB; Odo OJ; Sharndama HC; Okeke OP; Mba IE
    Microbiol Res; 2022 Nov; 264():127155. PubMed ID: 35969943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms.
    Hansen MF; Svenningsen SL; Røder HL; Middelboe M; Burmølle M
    Trends Microbiol; 2019 Sep; 27(9):739-752. PubMed ID: 31128928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A century of phage therapy: from novel discoveries about the past to the challenges of the today.
    Bach-Rojecky L; Lacković Z
    Pharmazie; 2021 Oct; 76(10):519-521. PubMed ID: 34620283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again.
    Squires RA
    N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phage Therapy Takes on Broad Applications.
    Mertz L
    IEEE Pulse; 2022; 13(5):9-15. PubMed ID: 36301810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming Bacteriophage Resistance in Phage Therapy.
    Laanto E
    Methods Mol Biol; 2024; 2738():401-410. PubMed ID: 37966611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage therapy: A renewed approach against oral diseases caused by Enterococcus faecalis infections.
    Yang D; Xiang Y; Song F; Li H; Ji X
    Microb Pathog; 2024 Apr; 189():106574. PubMed ID: 38354990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manufacturing of bacteriophages for therapeutic applications.
    João J; Lampreia J; Prazeres DMF; Azevedo AM
    Biotechnol Adv; 2021; 49():107758. PubMed ID: 33895333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.
    Aranaga C; Pantoja LD; Martínez EA; Falco A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy.
    Yeh TK; Jean SS; Lee YL; Lu MC; Ko WC; Lin HJ; Liu PY; Hsueh PR
    Int J Antimicrob Agents; 2022 Jan; 59(1):106475. PubMed ID: 34767917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M; Adamia R
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical data and safety assessment of phage therapy in humans.
    Nale JY; Clokie MR
    Curr Opin Biotechnol; 2021 Apr; 68():310-317. PubMed ID: 33862490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Overview on Bacteriophages: A Natural Nanostructured Antibacterial Agent.
    Rastogi V; Pragya ; Verma N; Mishra AK; Nath G; Gaur PK; Verma A
    Curr Drug Deliv; 2018; 15(1):3-20. PubMed ID: 27048165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review of Phage Therapy for Bone and Joint Infections.
    Ferry T
    Methods Mol Biol; 2024; 2734():207-235. PubMed ID: 38066372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basic Guidelines for Bacteriophage Isolation and Characterization.
    Samir S
    Recent Pat Biotechnol; 2023; 17(4):312-331. PubMed ID: 36263478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.